Biocon Inaugurates $30M FDA-Approved Manufacturing Plant in New Jersey, Expanding Capacity to 2 Billion Tablets Annually and Strengthening Global Supply Chain for Affordable Therapies
By Team VOH
Biocon has announced the launch of its first manufacturing facility in the United States, located in Cranbury